AcuPebble SA100 joins the NHS Innovation Accelerator 2021

AcuPebble SA100, the first medical device to obtain the CE mark for the automated diagnosis of Obstructive Sleep Apnoea, has been announced as one of 12 exciting innovations to join the NHS Innovation Accelerator 2021. This award-winning programme identifies early-stage solutions which address the most pressing needs of the NHS, and supports them over three years as they scale across England for the benefit of NHS patients and staff.

This year, the NIA’s rigorous, multi-stage selection process focused on finding evidence-based innovations to address the key NHS priorities of supporting the workforce, mental health and COVID-19 response. As a small wearable device which can be posted to patients and then used unsupervised at home, AcuPebble SA100 addresses the current pressing need for remote diagnostics, makes sleep apnoea testing more accessible and reduces waiting times, because a hospital visit is no longer required to supply the device and train the patient.